124 related articles for article (PubMed ID: 34155929)
41. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J
Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978
[TBL] [Abstract][Full Text] [Related]
42. Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.
Fang L; Cheng Q; Liu W; Zhang J; Ge Y; Zhang Q; Li L; Liu J; Zheng J
Cancer Biol Ther; 2016 Jun; 17(6):664-73. PubMed ID: 27195521
[TBL] [Abstract][Full Text] [Related]
43. Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor.
Fan JK; Xiao T; Gu JF; Wei N; He LF; Ding M; Liu XY
Biochem Biophys Res Commun; 2008 Sep; 374(2):198-203. PubMed ID: 18621025
[TBL] [Abstract][Full Text] [Related]
44. Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response.
Ren Z; Ye X; Fang C; Lu Q; Zhao Y; Liu F; Liang M; Hu F; Chen HZ
Cancer Biol Ther; 2008 Feb; 7(2):191-95. PubMed ID: 18073525
[TBL] [Abstract][Full Text] [Related]
45. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.
Zou H; Zheng YF; Ge W; Wang SB; Mou XZ
Sci Rep; 2018 Feb; 8(1):2182. PubMed ID: 29391509
[TBL] [Abstract][Full Text] [Related]
46. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
47. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.
Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN
Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613
[TBL] [Abstract][Full Text] [Related]
48. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
49. Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.
Xiao L; Li X; Niu N; Qian J; Xie G; Wang Y
Mol Cell Biochem; 2010 Jul; 340(1-2):31-40. PubMed ID: 20165905
[TBL] [Abstract][Full Text] [Related]
50. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
51. Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer.
Mao LJ; Ding M; Xu K; Pan J; Yu H; Yang C
J Cancer; 2018; 9(23):4391-4397. PubMed ID: 30519344
[TBL] [Abstract][Full Text] [Related]
52. Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
Yang M; Yang C; Tao Y; Tang J; Huang Q; Guo W; Feng S; Jiang A; Xu X; Jiang G; Liu Y
Cancer Med; 2018 Dec; 7(12):5928-5942. PubMed ID: 30406970
[TBL] [Abstract][Full Text] [Related]
53. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
[TBL] [Abstract][Full Text] [Related]
54. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Qian W; Liu J; Tong Y; Yan S; Yang C; Yang M; Liu X
Leukemia; 2008 Feb; 22(2):361-9. PubMed ID: 18046450
[TBL] [Abstract][Full Text] [Related]
55. An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells.
Yuan S; Fang X; Xu Y; Ni A; Liu XY; Chu L
Oncotarget; 2016 Sep; 7(37):60491-60502. PubMed ID: 27528029
[TBL] [Abstract][Full Text] [Related]
56. Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.
Qi R; Gu J; Zhang Z; Yang K; Li B; Fan J; Wang C; He Z; Qiao L; Lin Z; Liu XY
Cancer Gene Ther; 2007 Jan; 14(1):82-90. PubMed ID: 17008933
[TBL] [Abstract][Full Text] [Related]
57. Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer.
Jiang R; Zhang Z; Liao X; Huang L; Liao Y; Deng W
Ann Transl Med; 2021 Oct; 9(20):1527. PubMed ID: 34790733
[TBL] [Abstract][Full Text] [Related]
58. Cancer targeting gene-viro-therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.
Cao X; Wei R; Liu X; Zeng Y; Huang H; Ding M; Zhang K; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):813-21. PubMed ID: 21835849
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
[TBL] [Abstract][Full Text] [Related]
60. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.
Zhang L; Hedjran F; Larson C; Perez GL; Reid T
Cancer Gene Ther; 2015 Jan; 22(1):17-22. PubMed ID: 25525035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
